A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer

C. P. Belani, B. C. Chakraborty, R. I. Modi, Bakulesh Khamar

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences